Literature DB >> 29909251

fNIRS reveals enhanced brain activation to female (versus male) infant directed speech (relative to adult directed speech) in Young Human Infants.

Simone Sulpizio1, Hirokazu Doi2, Marc H Bornstein3, Joy Cui4, Gianluca Esposito5, Kazuyuki Shinohara6.   

Abstract

We hypothesized an association between auditory stimulus structure and activity in the brain that underlies infant auditory preference. In a within-infant design, we assessed brain activity to female and male infant directed relative to adult directed speech in 4-month-old infants using fNIRS. Results are compatible with the hypothesis that enhanced frontal brain activation, specifically in prefrontal cortex that is involved in emotion and reward, is evoked selectively by infant directed speech produced by female voices and may serve as a neuronal substrate for attention to and preference for "motherese" displayed by infants. Published by Elsevier Inc.

Entities:  

Keywords:  ADS; Female voice; IDS; Male voice; fNIRS

Mesh:

Year:  2018        PMID: 29909251      PMCID: PMC6528784          DOI: 10.1016/j.infbeh.2018.05.009

Source DB:  PubMed          Journal:  Infant Behav Dev        ISSN: 0163-6383


  3 in total

1.  The Metacognitive and Neurocognitive Signatures of Test Methods in Academic Listening.

Authors:  Jiayu Zhai; Vahid Aryadoust
Journal:  Front Psychol       Date:  2022-06-10

2.  Neural responses to affective speech, including motherese, map onto clinical and social eye tracking profiles in toddlers with ASD.

Authors:  Yaqiong Xiao; Teresa H Wen; Lauren Kupis; Lisa T Eyler; Disha Goel; Keith Vaux; Michael V Lombardo; Nathan E Lewis; Karen Pierce; Eric Courchesne
Journal:  Nat Hum Behav       Date:  2022-01-03

3.  Functional near-infrared spectroscopy in toddlers: Neural differentiation of communicative cues and relation to future language abilities.

Authors:  Elizabeth G Smith; Emma Condy; Afrouz Anderson; Audrey Thurm; Stacy S Manwaring; Lauren Swineford; Amir Gandjbakhche; Elizabeth Redcay
Journal:  Dev Sci       Date:  2020-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.